West Pharmaceutical Services | WST

Stock Price
368.66
Daily Change
-17.78 -4.60%
Monthly
-5.04%
Yearly
3.20%
Q2 Forecast
388.15
Peers Price Chg Day Year Date
4543 Terumo 2,608.50 15.50 0.60% -34.71% Apr/26
ALGN Align Technology 310.47 -4.11 -1.31% -12.43% Apr/25
AVNS Avanos Medical 17.85 -0.86 -4.60% -39.06% Apr/25
BAX Baxter International 40.25 -0.73 -1.78% -12.65% Apr/25
BDX Becton, Dickinson and Co. 230.77 -3.18 -1.36% -10.73% Apr/25
COO Cooper Companies 89.90 -0.35 -0.38% -5.12% Apr/25
CRL Charles River Laboratories 227.76 -11.87 -4.95% 21.79% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
HAE Haemonetics 87.66 1.44 1.67% 6.47% Apr/25
IART Integra LifeSciences 28.43 -0.95 -3.23% -47.55% Apr/25
ICUI ICU Medical 94.49 -2.23 -2.31% -47.84% Apr/25
IQV IQVIA Holdings 233.48 -7.37 -3.06% 22.90% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MMSI Merit Medical Systems 73.39 -0.64 -0.86% -5.51% Apr/25
NEOG Neogen 11.98 -0.39 -3.15% -28.78% Apr/25
PODD Insulet 164.03 -3.20 -1.91% -48.20% Apr/25
QDEL Quidel 39.68 -1.14 -2.79% -55.25% Apr/25
RGEN Repligen 165.70 -2.16 -1.29% 11.48% Apr/25
STAA STAAR Surgical 46.89 -0.93 -1.94% -30.64% Apr/25
WST West Pharmaceutical Services 368.66 -17.78 -4.60% 3.20% Apr/25
XRAY Dentsply International 30.35 -0.60 -1.92% -25.85% Apr/25

Indexes Price Day Year Date
RTY US2000 1981 -14.31 -0.72% 13.13% Apr/26
SPX US500 5082 -23.21 -0.46% 22.90% Apr/26

West Pharmaceutical Services traded at $368.66 this Thursday April 25th, decreasing $17.78 or 4.60 percent since the previous trading session. Looking back, over the last four weeks, West Pharmaceutical Services lost 5.04 percent. Over the last 12 months, its price rose by 3.20 percent. Looking ahead, we forecast West Pharmaceutical Services to be priced at 388.15 by the end of this quarter and at 366.33 in one year, according to Trading Economics global macro models projections and analysts expectations.

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.